Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

FXI vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, FXI returned −19.1% to XBI's +41.2%, and XBI charges 0.35% to FXI's 0.73%.

askIQ about this page

askIQ about FXI and XBI

Net assets: $3.7bn on Oct 28, 2026 for iShares China Large-Cap ETF, and $10.3bn on Oct 27, 2026 for State Street SPDR S&P Biotech ETF.

At a glance
−19.1%
FXI total return, 1 year
+41.2%
XBI total return, 1 year
0.73%
FXI expense ratio
0.35%
XBI expense ratio

Pair scorecard

XBI costs 0.38 points a year less; their one-year returns differ by 60.3 points; XBI is 2.8 times larger.

FXI vs XBI: Differences, Returns & Fees
MeasureFXIXBI
Return
Total return, 1 year−19.1%+41.2%
Drawdown
Below its high32.7%, high on Feb 17, 2021
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksFTSE China 50 IndexBiotech
Cost and size
Expense ratio0.73%0.35%
Net assets, as of Oct 26, 2026$3.7bn$10.2bn
Active share vs the S&P 50098%
Holdings
Holdings in common0%
Top ten holdings, share of the fund58.4%18%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, FXI and XBI hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first FXI XBI
Only in one fund ↓
Only in FXI
CHINA CONSTRUCTION BANK CORP H 9.81%
ALIBABA GROUP HOLDING 8.63%
TENCENT HOLDINGS 8.60%
INDUSTRIAL AND COMMERCIAL BANK OF 6.69%
XIAOMI 4.86%
BANK OF CHINA LTD H 4.76%
MEITUAN 4.58%
NETEASE 3.85%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
Check overlap with more funds →

Side by side

FXI iShares China Large-Cap ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Stock ETF Thematic ETF
What it is Tracks an index of China Large-Cap Biotech
Total return, 1 year −19.1% +41.2%
Expense ratio 0.73% 0.35%
Already in the S&P 500 0.0% 13.2%
Holdings 51 165
Net assets, FXI as of Oct 28, 2026 and XBI as of Oct 27, 2026 $3.7bn $10.3bn

FXI and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

FXI and XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
FXI

FXI tracks an index of China Large-Cap. Over the year to Oct 28, 2026 it returned −19.1% with distributions reinvested. The prospectus expense ratio is 0.73% a year. By its holdings published by its issuer for Oct 27, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 51 positions, with the top ten at 58.4%. It sat 32.7% below its high of Feb 17, 2021 on Oct 28, 2026.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are FXI and XBI in the same category?
FXI is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, FXI or XBI?
In the year to Oct 28, 2026, with distributions reinvested, FXI returned −19.1% and XBI +41.2%.
Which is cheaper, FXI or XBI?
XBI is cheaper, by 0.38 percentage points a year. That is about $38 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do FXI and XBI overlap with the S&P 500?
By their latest filed holdings, 0% of FXI and 13% of XBI by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, FXI against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/fxi-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.